| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas J. Salentine Jr. | Director | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| John Ackerman | Director | 2026-03-20 | 275,728 | $29.68 | $8.18MSell |
| Bindley Capital Partners I LLC | 10% Owner | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| William E. Bindley | Director | 2026-03-20 | 3,570,677 | $29.68 | $105.99MSell |
| Fred Burke | President and Chief Executive Officer | 2026-03-20 | 671,432 | $29.68 | $19.93MSell |
| Cardinal Equity Fund LP | Insider | 2026-03-20 | 275,728 | $29.68 | $8.18MSell |
| John Ackerman | Director | 2026-03-20 | 827,636 | $29.68 | $24.57MSell |
| Kendall Forbes | Executive Vice President Sales Operations | 2026-03-20 | 346,672 | $29.68 | $10.29MSell |
| David K. Morris | Executive Vice President and Chief Financial Officer | 2026-03-20 | 187,855 | $29.68 | $5.58MSell |
| Pharmacy Investors LLC | Insider | 2026-03-20 | 827,636 | $29.68 | $24.57MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Thomas J. Salentine Jr. | 43.06% | 27,274,871 | $1.10B | Insider |
| William E. Bindley | 43.00% | 27,239,157 | $1.10B | Insider |
| Bindley Capital Partners I LLC | 26.32% | 16,669,666 | $672.29M | Insider |
| John Ackerman | 13.29% | 8,417,090 | $339.46M | Insider |
| Pharmacy Investors LLC | 6.10% | 3,863,806 | $155.83M | Insider |
| Fred Burke | 5.43% | 3,438,064 | $138.66M | Insider |
| Kendall Forbes | 2.61% | 1,651,059 | $66.59M | Insider |
| Cardinal Equity Fund LP | 2.03% | 1,287,237 | $51.91M | Insider |
| David K. Morris | 1.42% | 896,341 | $36.15M | Insider |
| Jeffrey Tuch | 0.37% | 231,847 | $9.35M | Insider |